NRX PHARMACEUTICALS INC
NASDAQ: NRXP (NRX Pharmaceuticals, Inc.)
Last update: 2 hours ago3.13
-0.13 (-3.99%)
Previous Close | 3.26 |
Open | 3.25 |
Volume | 185,167 |
Avg. Volume (3M) | 261,995 |
Market Cap | 61,045,644 |
Price / Book | 2.90 |
52 Weeks Range | |
Earnings Date | 12 Aug 2025 - 18 Aug 2025 |
Diluted EPS (TTM) | -1.96 |
Current Ratio (MRQ) | 0.220 |
Operating Cash Flow (TTM) | -10.45 M |
Levered Free Cash Flow (TTM) | 3.23 M |
Return on Assets (TTM) | -191.74% |
Market Trend
Short Term | Medium Term | ||
Industry | Biotechnology (US) | Bearish | Bearish |
Biotechnology (Global) | Bearish | Bearish | |
Stock | NRX Pharmaceuticals, Inc. | Bullish | Bearish |
AIStockmoo Score
Analyst Consensus | 5.0 |
Insider Activity | NA |
Price Volatility | -4.5 |
Technical Moving Averages | 2.5 |
Technical Oscillators | 2.5 |
Average | 1.38 |
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior. |
|
Sector | Healthcare |
Industry | Biotechnology |
Investment Style | Small Core |
% Held by Insiders | 15.88% |
% Held by Institutions | 13.08% |
Ownership
Name | Date | Shares Held |
---|---|---|
Anson Funds Management Lp | 31 Mar 2025 | 1,179,061 |
Advisorshares Investments Llc | 31 Mar 2025 | 286,797 |
Townsquare Capital Llc | 31 Mar 2025 | 15,041 |
One Wealth Management Investment & Advisory Services, Llc | 31 Mar 2025 | 15,041 |
52 Weeks Range | ||
Price Target Range | ||
High | 46.00 (Ascendiant Capital, 1,369.65%) | Buy |
Median | 31.00 (890.42%) | |
Low | 18.00 (BTIG, 475.08%) | Buy |
Average | 31.67 (911.82%) | |
Total | 3 Buy | |
Avg. Price @ Call | 2.39 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
D. Boral Capital | 23 Jun 2025 | 31.00 (890.42%) | Buy | 3.10 |
20 Jun 2025 | 31.00 (890.42%) | Buy | 3.26 | |
Ascendiant Capital | 29 Apr 2025 | 46.00 (1,369.65%) | Buy | 2.06 |
BTIG | 02 Apr 2025 | 18.00 (475.08%) | Buy | 2.01 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |